The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the biological treatment of paraphilias
Author
dc.contributor.author
Thibaut, Florence
Author
dc.contributor.author
Barra, Flora De La
Author
dc.contributor.author
Gordon, Harvey
Author
dc.contributor.author
Cosyns, Paul
Author
dc.contributor.author
Bradford, John M.W.
Admission date
dc.date.accessioned
2019-03-11T12:59:22Z
Available date
dc.date.available
2019-03-11T12:59:22Z
Publication date
dc.date.issued
2010
Cita de ítem
dc.identifier.citation
World Journal of Biological Psychiatry, Volumen 11, Issue 4, 2018, Pages 604-655
Identifier
dc.identifier.issn
15622975
Identifier
dc.identifier.issn
18141412
Identifier
dc.identifier.other
10.3109/15622971003671628
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164990
Abstract
dc.description.abstract
Objectives. The primary aim of these guidelines was to evaluate the role of pharmacological agents in the treatment and management of paraphilia, with a focus on the treatment of adults males. Because such treatments are not delivered in isolation, the role of specific psychosocial and psychotherapeutic interventions was also briefly covered. These guidelines are intended for use in clinical practice by clinicians who diagnose and treat patients with paraphilia. The aim of these guidelines is to improve the quality of care and to aid physicians in clinical decisions. Methods. The aim of these guidelines was to bring together different views on the appropriate treatment of paraphilias from experts representing different continents. To achieve this aim, an extensive literature search was conducted using the English language literature indexed on MEDLINE/PubMed (19902009 for SSRIs) (19692009 for antiandrogen treatments), supplemented by other sources, including published reviews. Results.